Two points to consider:
1) A lot of Trophon 1 were wholey owned and may be traded in for a 2. That means they will pay for an upgrade to 2 and NAN gets to refurbish and sell the 1 into other less regulated markets competitively. These are also high margin sales as the customers are already found with high sales efficiency.
2) The leased 1's will again be available and the 2's will be leased at a higher rate for the better functions. The 2's are probably a bit more reliable so the service contract may have better margins as well.
Both point to more income either one off or ongoing.
All IMHO
- Forums
- ASX - By Stock
- NAN NOV 5 2020
Two points to consider: 1) A lot of Trophon 1 were wholey owned...
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAN (ASX) to my watchlist
|
|||||
Last
$3.31 |
Change
0.160(5.08%) |
Mkt cap ! $1.002B |
Open | High | Low | Value | Volume |
$3.37 | $3.48 | $3.28 | $13.77M | 4.080M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 60232 | $3.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.32 | 2090 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 47420 | 3.300 |
2 | 2622 | 3.290 |
4 | 14390 | 3.280 |
3 | 4950 | 3.270 |
2 | 6102 | 3.260 |
Price($) | Vol. | No. |
---|---|---|
3.370 | 14694 | 2 |
3.380 | 9738 | 2 |
3.390 | 9840 | 2 |
3.400 | 1102 | 1 |
3.410 | 1102 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
NAN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online